163 related articles for article (PubMed ID: 33594321)
1. Smad7 suppresses melanoma lung metastasis by impairing Tregs migration to the tumor microenvironment.
Ma D; Qiao L; Guo B
Am J Transl Res; 2021; 13(2):719-731. PubMed ID: 33594321
[TBL] [Abstract][Full Text] [Related]
2. SMAD7: a timer of tumor progression targeting TGF-β signaling.
Luo L; Li N; Lv N; Huang D
Tumour Biol; 2014 Sep; 35(9):8379-85. PubMed ID: 24935472
[TBL] [Abstract][Full Text] [Related]
3. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
4. Smad7 inhibits differentiation and mineralization of mouse osteoblastic cells.
Yano M; Inoue Y; Tobimatsu T; Hendy G; Canaff L; Sugimoto T; Seino S; Kaji H
Endocr J; 2012; 59(8):653-62. PubMed ID: 22673292
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
Hariharan R; Pillai MR
Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
[TBL] [Abstract][Full Text] [Related]
6. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
7. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
8. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of receptor-regulated and inhibitory Smads in lung fibroblasts from bleomycin-exposed rats.
Gonzalez AV; Le Bellego F; Ludwig MS
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):206-12. PubMed ID: 16931807
[TBL] [Abstract][Full Text] [Related]
10. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
13. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
14. Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells.
Landström M; Heldin NE; Bu S; Hermansson A; Itoh S; ten Dijke P; Heldin CH
Curr Biol; 2000 May; 10(9):535-8. PubMed ID: 10801443
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
17. [Studies of TGF-beta/Smads expression in lung cancer].
Shen JL; Yan CH; Liu Y; Yan XQ; Zhang XL; Jin Y; Zhang KF; Sang ZF; Zhang GY; Li P; Fu SB
Yi Chuan Xue Bao; 2003 Jul; 30(7):681-6. PubMed ID: 14579540
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin.
Lian GY; Wang QM; Mak TS; Huang XR; Yu XQ; Lan HY
Mol Ther Oncolytics; 2021 Mar; 20():277-289. PubMed ID: 33614911
[TBL] [Abstract][Full Text] [Related]
20. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
